EKF Diagnostics Holdings plc (AIM:EKF)
London · Delayed Price · Currency is GBP · Price in GBX 25.30
+0.30 (1.20%)
Sep 2, 2026, 4:35 PM GMT
EKF Diagnostics Holdings Market Cap
EKF Diagnostics Holdings has a market cap or net worth of 108.35 million as of September 2, 2026. Its market cap has decreased by -21.42% in one year.
Market Cap
108.35M
Enterprise Value
97.27M
Revenue
51.56M
Ranking
n/a
PE Ratio
53.84
Stock Price
25.30
ChartMarket Cap Chart
Since June 30, 2003, EKF Diagnostics Holdings's market cap has increased from 2.27M to 108.35M, an increase of 4,665.54%. That is a compound annual growth rate of 18.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 108.35M | -5.43% |
| Dec 31, 2025 | 114.57M | -6.48% |
| Dec 31, 2024 | 122.51M | -14.69% |
| Dec 29, 2023 | 143.61M | -36.87% |
| Dec 30, 2022 | 227.47M | -34.63% |
| Dec 31, 2021 | 347.95M | 6.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Smith & Nephew | 8.94B |
| NIOX Group | 284.51M |
| AOTI, Inc. | 135.61M |
| Creo Medical Group | 57.83M |
| Inspiration Healthcare Group | 17.04M |
| RUA Life Sciences | 16.45M |
| Proteome Sciences | 4.91M |
| Surgical Innovations Group | 3.96M |